Oncologic Safety and Surveillance of Autologous Fat Grafting following Breast Conservation Therapy
- 1 August 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Plastic and Reconstructive Surgery
- Vol. 146 (2), 215-225
- https://doi.org/10.1097/prs.0000000000006974
Abstract
Background: Autologous fat grafting is a useful adjunct following breast reconstruction. The impact of autologous fat grafting on oncologic safety and surveillance remains questionable, particularly following breast conservation therapy. Methods: The authors performed a retrospective review of patients who underwent delayed fat grafting following breast conservation therapy between 2006 and 2016. A control group of conservatively managed patients without grafting was matched for cancer stage, age, body mass index, and follow-up. Outcomes included locoregional recurrence and oncologic surveillance. Results: Seventy-two patients were identified per cohort. There were no differences in median age (50 years versus 51 years; p = 0.87), body mass index (28.2 kg/m2 versus 27.2 kg/m2; p = 0.38), or length of follow-up (61.9 months versus 66.8 months; p = 0.144) between controls and grafted patients, respectively. Overall, four patients in each cohort experienced recurrence (5.6 percent; p = 1.00) with similar cumulative incidence estimates observed (log-rank test, p = 0.534). There were no significant differences in palpable mass (9.7 percent versus 19.4 percent; p = 0.1), fat necrosis (34.7 percent versus 33.3 percent; p = 0.86), calcifications (37.5 percent versus 34.7 percent; p = 0.73), or indication for breast biopsy (15.3 percent versus 22.2 percent; p = 0.23) between breast conservation and breast conservation therapy plus autologous fat grafting cohorts, respectively. Conclusions: Overall, the authors found no difference in recurrence rates after breast conservation with or without delayed fat grafting. Furthermore, there were no differences in the rates of fat necrosis, palpable mass, and abnormal radiographic findings. This study represents the longest follow-up to date in in a large matched study of autologous fat grafting with breast conservation therapy demonstrating oncologic safety and no interference with follow-up surveillance. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.Keywords
This publication has 35 references indexed in Scilit:
- Patient-Reported Outcomes following Breast Conservation Therapy and Barriers to Referral for Partial Breast ReconstructionPlastic and Reconstructive Surgery, 2018
- Autologous Fat Grafting Reduces Pain in Irradiated Breast: A Review of Our ExperienceStem Cells International, 2015
- Change of Patient-Reported Aesthetic Outcome Over Time and Identification of Factors Characterizing Poor Aesthetic Outcome After Breast-Conserving Therapy: Long-Term Results of a Prospective Cohort StudyAnnals of Surgical Oncology, 2015
- Factors affecting cosmesis after breast conserving surgery without oncoplastic techniques in an experienced comprehensive breast centerThe Surgeon, 2015
- Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine modelJournal of Tissue Engineering and Regenerative Medicine, 2013
- Autologous Fat Graft in Postmastectomy Pain SyndromePlastic and Reconstructive Surgery, 2011
- Aesthetic outcomes in breast conservation therapyAesthetic Surgery Journal, 2008
- The Use of Radiation As a Component of Breast Conservation Therapy in National Comprehensive Cancer Network CentersJournal of Clinical Oncology, 2006
- Aesthetic Outcomes in Patients Undergoing Breast Conservation Therapy for the Treatment of Localized Breast CancerPlastic and Reconstructive Surgery, 2004
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerThe New England Journal of Medicine, 2002